Certified Global Research Member

Isomar fd.webp

Wcrc 57.webp

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players’ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Needle Free Injection Market Research Report information: Product (Fillable) Technology (Jet-Based) Usability (Reusable), Type of Medication (Liquid-Based), Site of Delivery (Intra dermal), Application (Vaccination) End Users (Hospitals)- Forecast Till 2030

ID: MRFR/HC/4721-CR | 100 Pages | Author: Kinjoll Dey| June 2018

Leading companies partner with us for data-driven Insights

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

1 Report Prologue

2 Market Introduction

2.1 Introduction 18

2.2 Assumptions & Limitations 18

3 Research Methodology

3.1 Research Process 21

3.2 Primary Research 21

3.3 Secondary Research 22

3.4 Market Size Estimation 22

4 Market Dynamics

4.1 Introduction 24

4.2 Drivers 24

4.2.1 Increasing Prevalence Of Chronic Conditions Such As Diabetes Is Estimated To Increase The Demand

For Needle-Free Injectors 24

4.2.2 Capacity Of Needle-Free Injectors To Support Homecare 24

4.2.3 Growing Biopharmaceuticals Industry 25

4.2.4 Increasing Investments In The Market 25

4.2.5 Drivers Impact Analysis 25

4.3 Restraints 26

4.3.1 Risks Of Cross Contamination 26

4.3.2 High Cost 26

4.3.3 Restraints Impact Analysis 26

4.4 Opportunity 27

4.4.1 Increasing Campaigns Of Vaccination In Developing Economies Of The Asia Pacific Region 27

4.5 Macroeconomic Indicators 27

5 Market Factor Analysis

5.1 Value Chain Analysis 29

5.1.1 R&D & Designing 29

5.1.2 Manufacturing 29

5.1.3 Distribution & Sales 29

5.1.4 Post-Sales Review 30

5.2 Porter’s Five Forces Model 31

5.2.1 Bargaining Power Of Suppliers 31

5.2.2 Bargaining Power Of Buyers 31

5.2.3 Threat Of New Entrants 32

5.2.4 Threat Of Substitutes 32

5.2.5 Intensity Of Rivalry 32

5.3 Investment Opportunities 32

5.4 Pricing Analysis 32

6 Needle Free Injection Market, By Product

6.1 Introduction 34

6.2 Fillable Needle-Free Injectors 35

6.3 Prefilled Needle-Free Injectors 35

7 Needle Free Injection Market, By Technology

7.1 Introduction 37

7.2 Jet-Based 38

7.3 Spring-Based 38

7.4 Laser-Powered 38

8 Global Needle Free Injection Market, By Usability

8.1 Introduction 40

8.2 Reusable Needle-Free Injectors 41

8.3 Disposable Needle-Free Injectors 41

9 Global Needle Free Injection Market, By Type Of Medication

9.1 Introduction 43

9.2 Liquid-Based Needle Free Injectors 44

9.3 Powder-Based Needle Free Injectors 44

9.4 Projectile/Depot-Based Needle Free Injectors 44

10 Needle Free Injection Market, By Site Of Delivery

10.1 Introduction 46

10.2 Intra Dermal Injectors 47

10.3 Intramuscular Injectors 47

10.4 Subcutaneous Injectors 47

11 Needle Free Injection Market, By Application

11.1 Introduction 49

11.2 Vaccination 50

11.3 Insulin Delivery 50

11.4 Oncology 50

12 Needle Free Injection Market, By End Users

12.1 Introduction 52

12.2 Hospitals And Clinics 53

12.3 Ambulatory Surgical Centres 53

12.4 Homecare Settings 53

13 Global Needle Free Injection Market, By Region

13.1 Introduction 55

13.2 Americas 56

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.2.1 North America 59

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.2.1.1 U.S 61

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.2.1.2 Canada 63

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.2.2 South America 65

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.3 Europe 68

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.3.1 Western Europe 71

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.3.1.1 Germany 73

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.3.1.2 France 75

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.3.1.3 U.K 77

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.3.1.4 Italy 79

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.3.1.5 Spain 81

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.3.1.6 Rest Of Western Europe 83

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.3.2 Eastern Europe 85

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.4 Asia Pacific 88

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.4.1 China 91

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.4.2 India 93

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.4.3 Japan 95

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.4.4 South Korea 97

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.4.5 Rest Of Asia Pacific 99

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.5 Middle East & Africa 102

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.6 The Middle East 105

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

13.6.1 Africa 107

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology

Needle Free Injection Market, By Site Of Delivery

Needle Free Injection Market, By Application

Needle Free Injection Market, By End Users

14 Competitive Landscape

14.1 Introduction 111

14.2 Recent Developments, 2014–2018 111

15 Company Profiles

15.1 Antares Pharma Inc. 114

15.1.1 Company Overview 114

15.1.2 Financial Overview 114

15.1.3 Products Offering 115

15.1.4 Key Developments 115

15.1.5 SWOT Analysis 115

15.1.6 Key Strategy 115

15.2 Endo Pharmaceuticals Inc. 116

15.2.1 Company Overview 116

15.2.2 Financial Overview 116

15.2.3 Products Offering 117

15.2.4 Key Developments 117

15.2.5 SWOT Analysis 117

15.2.6 Key Strategy 117

15.3 PharmaJet, Inc 118

15.3.1 Company Overview 118

15.3.2 Financial Overview 118

15.3.3 Products Offering 118

15.3.4 Key Developments 118

15.3.5 SWOT Analysis 118

15.3.6 Key Strategy 119

15.4 Inovio Pharmaceuticals Inc. 120

15.4.1 Company Overview 120

15.4.2 Financial Overview 120

15.4.3 Products Offering 121

15.4.4 Key Developments 121

15.4.5 SWOT Analysis 121

15.4.6 Key Strategy 121

15.5 Medical International Technology, Inc. 122

15.5.1 Company Overview 122

15.5.2 Financial Overview 122

15.5.3 Products Offering 122

15.5.4 Key Developments 122

15.5.5 SWOT Analysis 123

15.5.6 Key Strategy 123

15.6 INJEX Pharma GmBH 124

15.6.1 Company Overview 124

15.6.2 Financial Overview 124

15.6.3 Products Offering 124

15.6.4 Key Developments 124

15.6.5 SWOT Analysis 124

15.6.6 Key Strategy 124

15.7 National Medical Products Inc. 125

15.7.1 Company Overview 125

15.7.2 Financial Overview 125

15.7.3 Products Offering 125

15.7.4 Key Developments 125

15.7.5 SWOT Analysis 125

15.7.6 Key Strategy 125

15.8 European Pharma Group 126

15.8.1 Company Overview 126

15.8.2 Financial Overview 126

15.8.3 Products Offering 126

15.8.4 Key Developments 126

15.8.5 SWOT Analysis 126

15.8.6 Key Strategy 126

15.9 PenJet Corporation 127

15.9.1 Company Overview 127

15.9.2 Financial Overview 127

15.9.3 Products Offering 127

15.9.4 SWOT Analysis 127

15.9.5 Key Strategy 127

15.10 Valeritas Holdings, Inc. 128

15.10.1 Company Overview 128

15.10.2 Financial Overview 128

15.10.3 Products Offering 128

15.10.4 Key Developments 128

15.10.5 SWOT Analysis 129

15.10.6 Key Strategy 129

15.11 CROSSJECT 130

15.11.1 Company Overview 130

15.11.2 Financial Overview 130

15.11.3 Products Offering 130

15.11.4 Key Developments 130

15.11.5 SWOT Analysis 130

15.11.6 Key Strategy 131

15.12 MIKA MEDICAL CO. 132

15.12.1 Company Overview 132

15.12.2 Financial Overview 132

15.12.3 Products Offering 132

15.12.4 Key Developments 132

15.12.5 SWOT Analysis 132

15.12.6 Key Strategy 132

15.13 D'Antonio Consultants International, Inc. 133

15.13.1 Company Overview 133

15.13.2 Financial Overview 133

15.13.3 Products Offering 133

15.13.4 Key Developments 133

15.13.5 SWOT Analysis 133

15.13.6 Key Strategy 133

16 Appendix

16.1 Discussion Blue Print 135

17 List Of Tables

TABLE 1 GLOBAL NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 34

TABLE 2 GLOBAL NEEDLE FREE INJECTION MARKET FOR FILLABLE NEEDLE-FREE INJECTORS 2020-2027 (USD MILLION) 35

TABLE 3 GLOBAL NEEDLE FREE INJECTION MARKET FOR PREFILLED NEEDLE-FREE INJECTORS 2020-2027 (USD MILLION) 35

TABLE 4 GLOBAL NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 37

TABLE 5 GLOBAL NEEDLE FREE INJECTION MARKET FOR JET-BASED 2020-2027 (USD MILLION) 38

TABLE 6 GLOBAL NEEDLE FREE INJECTION MARKET FOR SPRING-BASED 2020-2027 (USD MILLION) 38

TABLE 7 GLOBAL NEEDLE FREE INJECTION MARKET FOR LASER-POWERED 2020-2027 (USD MILLION) 38

TABLE 8 GLOBAL NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 40

TABLE 9 GLOBAL NEEDLE FREE INJECTION MARKET FOR REUSABLE NEEDLE-FREE INJECTORS 2020-2027 (USD MILLION) 41

TABLE 10 GLOBAL NEEDLE FREE INJECTION MARKET FOR DISPOSABLE NEEDLE-FREE INJECTORS 2020-2027 (USD MILLION) 41

TABLE 11 GLOBAL NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 43

TABLE 12 GLOBAL NEEDLE FREE INJECTION MARKET FOR LIQUID-BASED NEEDLE FREE INJECTORS 2020-2027 (USD MILLION) 44

TABLE 13 GLOBAL NEEDLE FREE INJECTION MARKET FOR POWDER-BASED NEEDLE FREE INJECTORS 2020-2027 (USD MILLION) 44

TABLE 14 GLOBAL NEEDLE FREE INJECTION MARKET FOR PROJECTILE/DEPOT-BASED NEEDLE FREE INJECTORS

2020-2027 (USD MILLION) 44

TABLE 15 GLOBAL NEEDLE FREE INJECTION MARKET BY, TYPE OF SITE OF DELIVERY 2020-2027 (USD MILLION) 46

TABLE 16 GLOBAL NEEDLE FREE INJECTION MARKET FOR INTRA DERMAL INJECTORS 2020-2027 (USD MILLION) 47

TABLE 17 GLOBAL NEEDLE FREE INJECTION MARKET FOR INTRAMUSCULAR INJECTORS 2020-2027 (USD MILLION) 47

TABLE 18 GLOBAL NEEDLE FREE INJECTION MARKET FOR SUBCUTANEOUS INJECTORS 2020-2027 (USD MILLION) 47

TABLE 19 GLOBAL NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 49

TABLE 20 GLOBAL NEEDLE FREE INJECTION MARKET FOR VACCINATION 2020-2027 (USD MILLION) 50

TABLE 21 GLOBAL NEEDLE FREE INJECTION MARKET FOR INSULIN DELIVERY 2020-2027 (USD MILLION) 50

TABLE 22 GLOBAL NEEDLE FREE INJECTION MARKET FOR ONCOLOGY 2020-2027 (USD MILLION) 50

TABLE 23 GLOBAL NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 52

TABLE 24 GLOBAL NEEDLE FREE INJECTION MARKET FOR HOSPITALS AND CLINICS 2020-2027 (USD MILLION) 53

TABLE 25 GLOBAL NEEDLE FREE INJECTION MARKET FOR AMBULATORY SURGICAL CENTRES 2020-2027 (USD MILLION) 53

TABLE 26 GLOBAL NEEDLE FREE INJECTION MARKET FOR HOMECARE SETTINGS 2020-2027 (USD MILLION) 53

TABLE 27 GLOBAL NEEDLE FREE INJECTION MARKET BY, REGION 2020-2027 (USD MILLION) 55

TABLE 28 AMERICAS NEEDLE FREE INJECTION MARKET BY, REGION 2020-2027 (USD MILLION) 56

TABLE 29 AMERICAS NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 56

TABLE 30 AMERICAS NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 57

TABLE 31 AMERICAS NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 57

TABLE 32 AMERICAS NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 57

TABLE 33 AMERICAS NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 57

TABLE 34 AMERICAS NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 58

TABLE 35 AMERICAS NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 58

TABLE 36 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 59

TABLE 37 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 59

TABLE 38 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 59

TABLE 39 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 60

TABLE 40 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 60

TABLE 41 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 60

TABLE 42 NORTH AMERICA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 61

TABLE 43 U.S NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 61

TABLE 44 U.S NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 61

TABLE 45 U.S NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 62

TABLE 46 U.S NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 62

TABLE 47 U.S NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 62

TABLE 48 U.S NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 62

TABLE 49 U.S NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 63

TABLE 50 CANADA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 63

TABLE 51 CANADA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 63

TABLE 52 CANADA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 64

TABLE 53 CANADA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 64

TABLE 54 CANADA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 64

TABLE 55 CANADA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 64

TABLE 56 CANADA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 65

TABLE 57 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 65

TABLE 58 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 65

TABLE 59 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 66

TABLE 60 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 66

TABLE 61 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 66

TABLE 62 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 66

TABLE 63 SOUTH AMERICA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 67

TABLE 64 EUROPE NEEDLE FREE INJECTION MARKET BY, REGION 2020-2027 (USD MILLION) 68

TABLE 65 EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 69

TABLE 66 EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 69

TABLE 67 EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 69

TABLE 68 EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 69

TABLE 69 EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 70

TABLE 70 EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 70

TABLE 71 EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 70

TABLE 72 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 71

TABLE 73 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 71

TABLE 74 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 71

TABLE 75 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 72

TABLE 76 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 72

TABLE 77 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 72

TABLE 78 WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 73

TABLE 79 GERMANY NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 73

TABLE 80 GERMANY NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 73

TABLE 81 GERMANY NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 74

TABLE 82 GERMANY NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 74

TABLE 83 GERMANY NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 74

TABLE 84 GERMANY NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 74

TABLE 85 GERMANY NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 75

TABLE 86 FRANCE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 75

TABLE 87 FRANCE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 75

TABLE 88 FRANCE NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 76

TABLE 89 FRANCE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 76

TABLE 90 FRANCE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 76

TABLE 91 FRANCE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 76

TABLE 92 FRANCE NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 77

TABLE 93 U.K NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 77

TABLE 94 U.K NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 77

TABLE 95 U.K NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 78

TABLE 96 U.K NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 78

TABLE 97 U.K NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 78

TABLE 98 U.K NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 78

TABLE 99 U.K NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 79

TABLE 100 ITALY NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 79

TABLE 101 ITALY NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 79

TABLE 102 ITALY NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 80

TABLE 103 ITALY NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 80

TABLE 104 ITALY NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 80

TABLE 105 ITALY NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 80

TABLE 106 ITALY NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 81

TABLE 107 SPAIN NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 81

TABLE 108 SPAIN NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 81

TABLE 109 SPAIN NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 82

TABLE 110 SPAIN NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 82

TABLE 111 SPAIN NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 82

TABLE 112 SPAIN NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 82

TABLE 113 SPAIN NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 83

TABLE 114 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 83

TABLE 115 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 83

TABLE 116 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 84

TABLE 117 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 84

TABLE 118 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 84

TABLE 119 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 84

TABLE 120 REST OF WESTERN EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 85

TABLE 121 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 85

TABLE 122 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 85

TABLE 123 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 86

TABLE 124 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 86

TABLE 125 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 86

TABLE 126 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 86

TABLE 127 EASTERN EUROPE NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 87

TABLE 128 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, REGION 2020-2027 (USD MILLION) 88

TABLE 129 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 88

TABLE 130 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 89

TABLE 131 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 89

TABLE 132 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 89

TABLE 133 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 89

TABLE 134 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 90

TABLE 135 ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 90

TABLE 136 CHINA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 91

TABLE 137 CHINA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 91

TABLE 138 CHINA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 91

TABLE 139 CHINA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 92

TABLE 140 CHINA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 92

TABLE 141 CHINA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 92

TABLE 142 CHINA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 93

TABLE 143 INDIA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 93

TABLE 144 INDIA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 93

TABLE 145 INDIA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 94

TABLE 146 INDIA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 94

TABLE 147 INDIA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 94

TABLE 148 INDIA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 94

TABLE 149 INDIA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 95

TABLE 150 JAPAN NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 95

TABLE 151 JAPAN NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 95

TABLE 152 APAN NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 96

TABLE 153 JAPAN NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 96

TABLE 154 JAPAN NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 96

TABLE 155 JAPAN NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 96

TABLE 156 JAPAN NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 97

TABLE 157 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 97

TABLE 158 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 97

TABLE 159 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 98

TABLE 160 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 98

TABLE 161 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 98

TABLE 162 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 98

TABLE 163 SOUTH KOREA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 99

TABLE 164 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 99

TABLE 165 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 99

TABLE 166 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 100

TABLE 167 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 100

TABLE 168 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 100

TABLE 169 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 100

TABLE 170 REST OF ASIA PACIFIC NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 101

TABLE 171 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, REGION 2020-2027 (USD MILLION) 102

TABLE 172 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 102

TABLE 173 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 103

TABLE 174 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 103

TABLE 175 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 103

TABLE 176 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 103

TABLE 177 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 104

TABLE 178 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 104

TABLE 179 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 105

TABLE 180 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 105

TABLE 181 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 105

TABLE 182 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 106

TABLE 183 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 106

TABLE 184 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 106

TABLE 185 THE MIDDLE EAST NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 107

TABLE 186 AFRICA NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020-2027 (USD MILLION) 107

TABLE 187 AFRICA NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020-2027 (USD MILLION) 107

TABLE 188 AFRICA NEEDLE FREE INJECTION MARKET BY, USABILITY 2020-2027 (USD MILLION) 108

TABLE 189 AFRICA NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020-2027 (USD MILLION) 108

TABLE 190 AFRICA NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020-2027 (USD MILLION) 108

TABLE 191 AFRICA NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020-2027 (USD MILLION) 108

TABLE 192 AFRICA NEEDLE FREE INJECTION MARKET BY, END USER 2020-2027 (USD MILLION) 109

18 List Of Figures

FIGURE 1 MARKET STRUCTURE 19

FIGURE 2 RESEARCH PROCESS 21

FIGURE 3 DROC ANALYSIS OF GLOBAL NEEDLE FREE INJECTION MARKET 24

FIGURE 4 DRIVERS IMPACT ANALYSIS: GLOBAL NEEDLE FREE INJECTION MARKET 25

FIGURE 5 RESTRAINTS IMPACT ANALYSIS: NEEDLE FREE INJECTION MARKET 26

FIGURE 6 VALUE CHAIN: GLOBAL NEEDLE-FREE INJECTION MARKET 29

FIGURE 7 PORTER’S FIVE FORCES MODEL: GLOBAL NEEDLE-FREE INJECTION MARKET 31

FIGURE 8 GLOBAL NEEDLE FREE INJECTION MARKET BY, PRODUCT 2020 & 2027 (USD MILLION) 34

FIGURE 9 GLOBAL NEEDLE FREE INJECTION MARKET BY, TECHNOLOGY 2020 & 2027 (USD MILLION) 37

FIGURE 10 GLOBAL NEEDLE FREE INJECTION MARKET BY, USABILITY 2020 & 2027 (USD MILLION) 40

FIGURE 11 GLOBAL NEEDLE FREE INJECTION MARKET BY, TYPE OF MEDICATION 2020 & 2027 (USD MILLION) 43

FIGURE 12 GLOBAL NEEDLE FREE INJECTION MARKET BY, SITE OF DELIVERY 2020 & 2027 (USD MILLION) 46

FIGURE 13 GLOBAL NEEDLE FREE INJECTION MARKET BY, APPLICATION 2020 & 2027 (USD MILLION) 49

FIGURE 14 GLOBAL NEEDLE FREE INJECTION MARKET BY, END USER 2020 & 2027 (USD MILLION) 52

FIGURE 15 GLOBAL NEEDLE FREE INJECTION MARKET SHARE BY, REGION 2020 (%) 55

FIGURE 16 AMERICAS NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2020 (%) 56

FIGURE 17 EUROPE NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2020 (%) 68

FIGURE 18 ASIA PACIFIC NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2020 (%) 88

FIGURE 19 MIDDLE EAST & AFRICA NEEDLE FREE INJECTION MARKET SAHRE BY, REGION 2020 (%) 102

FIGURE 20 GLOBAL NEEDLE FREE INJECTION MARKET, COMPETITIVE LANDSCAPE, 2020 (%) 111

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.

Related Reports

Needle Free Injection Market Research Report – Forecast to 2030

Press Release

Needle Free Injection Market to be Worth USD 25,057.4 Million by 2023

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions

© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)